Position β57 of I-A g7 controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset
- 2 August 2019
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 4 (38)
- https://doi.org/10.1126/sciimmunol.aaw6329
Abstract
The class II region of the major histocompatibility complex (MHC) locus is the main contributor to the genetic susceptibility to type 1 diabetes (T1D). The loss of an aspartic acid at position 57 of diabetogenic HLA-DQβ chains supports this association; this single amino acid change influences how TCRs recognize peptides in the context of HLA-DQ8 and I-Ag7 using a mechanism termed the P9 switch. Here, we built register-specific insulin peptide MHC tetramers to examine CD4+ T cell responses to Ins12–20 and Ins13–21 peptides during the early prediabetic phase of disease in nonobese diabetic (NOD) mice. A single-cell analysis of anti-insulin CD4+ T cells performed in 6- and 12-week-old NOD mice revealed tissue-specific gene expression signatures. TCR signaling and clonal expansion were found only in the islets of Langerhans and produced either classical TH1 differentiation or an unusual Treg phenotype, independent of TCR usage. The early phase of the anti-insulin response was dominated by T cells specific for Ins12–20, the register that supports a P9 switch mode of recognition. The presence of the P9 switch was demonstrated by TCR sequencing, reexpression, mutagenesis, and functional testing of TCRαβ pairs in vitro. Genetic correction of the I-Aβ57 mutation in NOD mice resulted in the disappearance of D/E residues in the CDR3β of anti-Ins12–20 T cells. These results provide a mechanistic molecular explanation that links the characteristic MHC class II polymorphism of T1D with the recognition of islet autoantigens and disease onset.Keywords
Funding Information
- National Institutes of Health (UL1TR002550, TL1TR002551)
- National Institutes of Health (UL1TR002550, TL1TR002551)
- National Institutes of Health (UL1TR002550, KL2TR001112)
- National Institutes of Health (R01DK099317)
- National Institutes of Health (DK097605 and DK107541)
- National Institutes of Health (1R01DK117138)
- National Institutes of Health (RO1DK058177)
This publication has 61 references indexed in Scilit:
- Type 1 Diabetes-associated HLA-DQ8 Transdimer Accommodates a Unique Peptide RepertoireOnline Journal of Public Health Informatics, 2012
- Register shifting of an insulin peptide–MHC complex allows diabetogenic T cells to escape thymic deletionThe Journal of Experimental Medicine, 2011
- Specificity and detection of insulin-reactive CD4+T cells in type 1 diabetes in the nonobese diabetic (NOD) mouseProceedings of the National Academy of Sciences of the United States of America, 2011
- Assignment of PolyProline II Conformation and Analysis of Sequence – Structure RelationshipPLOS ONE, 2011
- Diabetogenic T cells recognize insulin bound to IAg7in an unexpected, weakly binding registerProceedings of the National Academy of Sciences of the United States of America, 2010
- Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNγDiabetologia, 2010
- The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinityJCI Insight, 2010
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cellsThe Journal of Experimental Medicine, 2009
- Weak Proinsulin Peptide–Major Histocompatibility Complexes Are Targeted in Autoimmune Diabetes in MiceDiabetes, 2008
- Extreme genetic risk for type 1A diabetesProceedings of the National Academy of Sciences of the United States of America, 2006